Abivax Sa ADR (ABVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Operating Expenses | 187,185 | 137,859 | 68,311 |
| Operating Income | -187,186 | -137,859 | -68,311 |
| Interest Expense | 18,386 | 30,169 | 7,398 |
| Other Income | 14,861 | 8,129 | 11,714 |
| Pre-tax Income | -190,712 | -159,899 | -63,996 |
| Net Income Continuous | -190,712 | -159,899 | -63,996 |
| Net Income | $-190,712 | $-159,899 | $-63,996 |
| EPS Basic Total Ops | -3.03 | -3.71 | -3.35 |
| EPS Basic Continuous Ops | -3.03 | -3.71 | -3.35 |
| EPS Diluted Total Ops | -3.03 | -3.71 | -3.35 |
| EPS Diluted Continuous Ops | -3.03 | -3.71 | -3.35 |
| EPS Diluted Before Non-Recurring Items | -3.03 | N/A | N/A |
| EBITDA(a) | $-185,995 | $-137,094 | $-67,800 |